The FDA approved Pfizer's nasal spray for migraines, giving patients access to a potentially fast-acting pain relief option.
Pfizer is hoping to gain a competitive edge with Zavzpret, and Biohaven has pitched it as the “Epipen of migraine.”The Food and Drug Administration on Friday approved Pfizer's nasal spray for migraines, giving patients access to a potentially fast-acting pain relief option.
The drug, whose pricing will be revealed at its launch in July, is “expected to be comparable in price to other FDA approved migraine medicines” which belong to the same class, Pfizer told Reuters. The new drug isn't the first nasal spray for migraines, although Dr. Emad Estemalik, a headache specialist at the Cleveland Clinic, said the quick, 15-minute relief gives the drug an advantage over the existing oral treatments.
Halker Singh, who is also on the board of the American Headache Society, is excited about the new medication, although she notes that about 20% of patients in the clinical trial experienced an altered sense of taste, compared to about 4.7% of patients who were given a placebo.
France Dernières Nouvelles, France Actualités
Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.
FDA approves Pfizer's new nasal spray treatment for migrainesThe FDA approved Pfizer's newest drug on the migraine market, Zavzpret (zavegepant), the first and only migraine treatment offered in a nasal spray.
Lire la suite »
Pfizer wins FDA approval for its migraine nasal sprayPfizer Inc. said Friday the U.S. Food and Drug Administration has approved its migraine nasal spray Zavzpret. The treatment is the first and only calcitonin...
Lire la suite »
US FDA approves Pfizer's pain-relief nasal spray for migraineThe U.S. Food and Drug Administration on Friday approved Pfizer Inc's nasal spray for migraine, giving patients access to a potentially fast-acting pain-relief option for headaches.
Lire la suite »
US FDA approves Pfizer's nasal spray for migraineThe U.S. Food and Drug Administration on Friday approved Pfizer Inc's nasal spray for migraine, giving patients access to a potentially fast-acting pain-relief option for headaches.
Lire la suite »
FDA approves new nasal spray to treat migraine headaches in adults, Pfizer says | CNNThe FDA has approved a new nasal spray as a rapid treatment for migraine pain in adults. The spray may relieve pain and other migraine symptoms as soon as 15 minutes after use, drugmaker Pfizer says.
Lire la suite »
FDA Approves Amphastar Pharma's Nasal Spray for Opioid OverdoseAmphastar Pharmaceuticals Inc said on Wednesday the FDA had approved its nasal spray for emergency treatment of known or suspected opioid overdose.
Lire la suite »